ADEL K EL-NAGGAR to Loss of Heterozygosity
This is a "connection" page, showing publications ADEL K EL-NAGGAR has written about Loss of Heterozygosity.
Connection Strength
1.239
-
Molecular and clinicopathologic comparisons of head and neck squamous carcinoma variants: common and distinctive features of biological significance. Am J Surg Pathol. 2004 Oct; 28(10):1299-310.
Score: 0.207
-
Genetic heterogeneity in saliva from patients with oral squamous carcinomas: implications in molecular diagnosis and screening. J Mol Diagn. 2001 Nov; 3(4):164-70.
Score: 0.169
-
Loss of imprinting and genetic alterations of the cyclin-dependent kinase inhibitor p57KIP2 gene in head and neck squamous cell carcinoma. Clin Cancer Res. 2000 Aug; 6(8):3172-6.
Score: 0.155
-
Genetic alterations in acinic cell carcinoma of the parotid gland determined by microsatellite analysis. Cancer Genet Cytogenet. 1998 Apr 01; 102(1):19-24.
Score: 0.132
-
Allelic loss and replication errors at microsatellite loci on chromosome 11p in head and neck squamous carcinoma: association with aggressive biological features. Clin Cancer Res. 1996 May; 2(5):903-7.
Score: 0.116
-
Sarcomatoid carcinoma of the head and neck: molecular evidence for evolution and progression from conventional squamous cell carcinomas. Am J Surg Pathol. 2003 Sep; 27(9):1216-20.
Score: 0.048
-
Molecular analysis of chromosome 16q regions in dermal analogue tumors of salivary glands: a genetic link to dermal cylindroma? Am J Surg Pathol. 2002 Jun; 26(6):778-83.
Score: 0.044
-
High frequency loss of heterozygosity in von Hippel-Lindau (VHL)-associated and sporadic pancreatic islet cell tumors: evidence for a stepwise mechanism for malignant conversion in VHL tumorigenesis. Cancer Res. 2002 Apr 01; 62(7):1952-5.
Score: 0.044
-
Molecular and biomarker analyses of salivary duct carcinomas: comparison with mammary duct carcinoma. Int J Oncol. 2001 Oct; 19(4):865-71.
Score: 0.042
-
Molecular genetic alterations in carcinoma ex-pleomorphic adenoma: a putative progression model? Genes Chromosomes Cancer. 2000 Feb; 27(2):162-8.
Score: 0.038
-
Genetic alterations in oral squamous cell carcinoma of young adults. Oral Oncol. 1999 May; 35(3):251-6.
Score: 0.036
-
Genotypic analysis of flow-sorted and microdissected head and neck squamous lesions by whole-genome amplification. Diagn Mol Pathol. 1998 Aug; 7(4):197-201.
Score: 0.034
-
Localization of chromosome 8p regions involved in early tumorigenesis of oral and laryngeal squamous carcinoma. Oncogene. 1998 Jun 11; 16(23):2983-7.
Score: 0.033
-
Intratumoral genetic heterogeneity in primary head and neck squamous carcinoma using microsatellite markers. Diagn Mol Pathol. 1997 Dec; 6(6):305-8.
Score: 0.032
-
Microsatellite alterations at chromosome 8q loci in pleomorphic adenoma. Otolaryngol Head Neck Surg. 1997 Nov; 117(5):448-52.
Score: 0.032
-
Erlotinib and the Risk of Oral Cancer: The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical Trial. JAMA Oncol. 2016 Feb; 2(2):209-16.
Score: 0.028
-
Cyclin D1 and p16 alterations in advanced premalignant lesions of the upper aerodigestive tract: role in response to chemoprevention and cancer development. Clin Cancer Res. 2001 Oct; 7(10):3127-34.
Score: 0.011
-
Alterations of the DNA repair gene OGG1 in human clear cell carcinomas of the kidney. Cancer Res. 2000 Sep 01; 60(17):4740-4.
Score: 0.010
-
Predicting cancer development in oral leukoplakia: ten years of translational research. Clin Cancer Res. 2000 May; 6(5):1702-10.
Score: 0.010
-
High metastatic potential in mice inheriting a targeted p53 missense mutation. Proc Natl Acad Sci U S A. 2000 Apr 11; 97(8):4174-9.
Score: 0.010
-
Phenotype and genotype of advanced premalignant head and neck lesions after chemopreventive therapy. J Natl Cancer Inst. 1998 Oct 21; 90(20):1545-51.
Score: 0.009